Clinical Trials Directory

Trials / Completed

CompletedNCT01723111

Impact of Dialysis Modality on Hepcidin and Iron Metabolism

A Prospective, Multicenter, Observational Study to Evaluate the Impact of Peritoneal Dialysis Compared With Hemodialysis on Iron Metabolism and Hepcidin

Status
Completed
Phase
Study type
Observational
Enrollment
120 (actual)
Sponsor
Kyungpook National University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

* Dialysis modality may influence the oxidative stress and proinflammatory cytokines in ESRD patients. * Dialysis modality may affect hepcidin * Dialysis modality may influence iron and ESA requirements.

Detailed description

It has been considered that PD patients tended to be less anemic and require lower ESA dose than HD patients. In addition, it was also known that the level of oxidative stress and inflammatory cytokines tended to be lower in PD patients than HD patients. And hepcidin synthesis is markedly increased during inflammation. Altogether, Lower ESA requirement in PD patients may be associated with lower hepcidin level due to lower inflammatory state compared with HD patients.

Conditions

Timeline

Start date
2012-11-01
Primary completion
2016-02-01
Completion
2016-08-01
First posted
2012-11-07
Last updated
2017-08-22

Locations

4 sites across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01723111. Inclusion in this directory is not an endorsement.